SCHEMBL29348461

SCHEMBL29348461

O=C1CCC(c2cccc(-c3ccc(CC(=O)N4CCCC4)cc3)c2Cl)C(=O)N1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRKAB2 O43741 1/20 0.39
PRKAG1 P54619 1/20 0.39
PRKAA2 P54646 1/20 0.39
PRKAA1 Q13131 1/20 0.39
PRKAG3 Q9UGI9 1/20 0.39
PRKAG2 Q9UGJ0 1/20 0.39
PRKAB1 Q9Y478 1/20 0.39
DDB1 Q16531 8/20 0.39
CRBN Q96SW2 8/20 0.39
JAK1 P23458 4/20 0.39
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
JAK2 O60674 2/20 0.37
HRH3 Q9Y5N1 1/20 0.36
POLB P06746 1/20 0.36
GSPT1 P15170 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31068101 1.00 PRKAB2 (0.39) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL29348412 0.85 CREBBP (0.48) DDB1CRBNHPGDSMN1; SMN2ALDH1A1
SCHEMBL31068121 0.84 CREBBP (0.47) DDB1CRBNNPC1HPGDSMN1; SMN2
SCHEMBL29348783 0.84 CREBBP (0.47) DDB1CRBNNPC1HPGDSMN1; SMN2
SCHEMBL31068261 0.83 DDB1 (0.47) DDB1CRBNGSPT1
SCHEMBL29348711 0.83 DDB1 (0.47) DDB1CRBNGSPT1
SCHEMBL29348473 0.83 KMT2A (0.41) DDB1CRBNNPC1SMN1; SMN2ALDH1A1
SCHEMBL31068201 0.83 KMT2A (0.41) DDB1CRBNNPC1SMN1; SMN2ALDH1A1
SCHEMBL29348399 0.82 HRH3 (0.45) DDB1CRBNHRH3GSPT1
SCHEMBL31068190 0.81 HPGD (0.39) DDB1CRBNHPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed